{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:16:24Z","timestamp":1792664184296,"version":"4.5.0"},"reference-count":70,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Plasminogen deficiency is associated with severely compromised fibrinolysis and extravascular deposition of fibrin. In contrast, coagulation factor VIII (FVIII) deficiency leads to prolonged and excessive bleeding. Based on opposing biological functions of plasminogen and FVIII deficiencies, we hypothesized that genetic elimination of FVIII would alleviate the systemic formation of fibrin deposits associated with plasminogen deficiency and, in turn, elimination of plasminogen would limit bleeding symptoms associated with FVIII deficiency. Mice with single and combined deficiencies of FVIII (F8\u2212\/\u2212) and plasminogen (Plg\u2212\/\u2212) were evaluated for phenotypic characteristics of plasminogen deficiency, including wasting disease, shortened lifespan, rectal prolapse, and multiorgan fibrin deposition. Conversely, to specifically examine the role of plasmin-mediated fibrinolysis on bleeding caused by FVIII deficiency, F8\u2212\/\u2212 and F8\u2212\/\u2212\/Plg\u2212\/\u2212 mice were subjected to a bleeding challenge. Mice with a combined deficiency in FVIII and plasminogen displayed no phenotypic differences relative to mice with single FVIII or plasminogen deficiency. Plg\u2212\/\u2212 and F8\u2212\/\u2212\/Plg\u2212\/\u2212 mice exhibited the same penetrance and severity of wasting disease, rectal prolapse, extravascular fibrin deposits, and reduced viability. Furthermore, following a tail vein\u2013bleeding challenge, no significant differences in bleeding times or total blood loss could be detected between F8\u2212\/\u2212 and F8\u2212\/\u2212\/Plg\u2212\/\u2212 mice. Moreover, F8\u2212\/\u2212 and F8\u2212\/\u2212\/Plg\u2212\/\u2212 mice responded similarly to recombinant FVIII (rFVIII) therapy. In summary, the pathological phenotype of Plg\u2212\/\u2212 mice developed independently of FVIII-dependent coagulation, and elimination of plasmin-driven fibrinolysis did not play a significant role in a nonmucosal bleeding model in hemophilia A mice.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018024851","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T11:49:22Z","timestamp":1542714562000},"page":"3126-3136","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice"],"prefix":"10.1182","volume":"2","author":[{"given":"Rikke","family":"Stagaard","sequence":"first","affiliation":[{"name":"Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children\u2019s Research Foundation, Cincinnati, OH;"},{"name":"Global Drug Discovery, Novo Nordisk A\/S, M\u00e5l\u00f8v, Denmark; and"},{"name":"Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8119-2224","authenticated-orcid":false,"given":"Carsten Dan","family":"Ley","sequence":"additional","affiliation":[{"name":"Global Drug Discovery, Novo Nordisk A\/S, M\u00e5l\u00f8v, Denmark; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9250-514X","authenticated-orcid":false,"given":"Kasper","family":"Almholt","sequence":"additional","affiliation":[{"name":"Global Drug Discovery, Novo Nordisk A\/S, M\u00e5l\u00f8v, Denmark; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0292-3111","authenticated-orcid":false,"given":"Lisbeth H\u00f8ier","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6868-239X","authenticated-orcid":false,"given":"Tom","family":"Knudsen","sequence":"additional","affiliation":[{"name":"Global Drug Discovery, Novo Nordisk A\/S, M\u00e5l\u00f8v, Denmark; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Flick","sequence":"additional","affiliation":[{"name":"Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children\u2019s Research Foundation, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"issue":"3","key":"2020021108405185000_B1","doi-asserted-by":"crossref","first-page":"e0122196","DOI":"10.1371\/journal.pone.0122196","article-title":"Endogenously generated plasmin at the vascular wall injury site amplifies lysine binding site-dependent plasminogen accumulation in microthrombi","volume":"10","author":"Brzoska","year":"2015","journal-title":"PLoS One"},{"issue":"6470","key":"2020021108405185000_B2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/368419a0","article-title":"Physiological consequences of loss of plasminogen activator gene function in mice","volume":"368","author":"Carmeliet","year":"1994","journal-title":"Nature"},{"issue":"12","key":"2020021108405185000_B3","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1111\/j.1538-7836.2007.02776.x","article-title":"Plasminogen deficiency","volume":"5","author":"Schuster","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2020021108405185000_B4","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1182\/blood-2006-04-017350","article-title":"Molecular and clinical spectrum of type I plasminogen deficiency: a series of 50 patients","volume":"108","author":"Tefs","year":"2006","journal-title":"Blood"},{"issue":"6","key":"2020021108405185000_B5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2516.2008.01825.x","article-title":"Plasminogen deficiency","volume":"14","author":"Mehta","year":"2008","journal-title":"Haemophilia"},{"issue":"12","key":"2020021108405185000_B6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1182\/blood-2017-09-806729","article-title":"Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency","volume":"131","author":"Shapiro","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2020021108405185000_B7","doi-asserted-by":"crossref","first-page":"1334317","DOI":"10.1080\/2331205X.2017.1334317","article-title":"Type I plasminogen deficiency with unexpected clinical aspects: could be more than coexistence?","volume":"4","author":"Alt\u0131ner","year":"2017","journal-title":"Cogent Med"},{"issue":"3","key":"2020021108405185000_B8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11239-015-1225-3","article-title":"Beyond hemostasis: the challenge of treating plasminogen deficiency. A report of three cases","volume":"41","author":"Pons","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"2020021108405185000_B9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/hae.13418","article-title":"Ligneous cervicitis and endometritis: a gynaecological presentation of congenital plasminogen deficiency","volume":"24","author":"Baithun","year":"2018","journal-title":"Haemophilia"},{"issue":"2","key":"2020021108405185000_B10","doi-asserted-by":"crossref","first-page":"e26779","DOI":"10.1002\/pbc.26779","article-title":"Treatment of plasminogen deficiency patients with fresh frozen plasma","volume":"65","author":"K\u0131z\u0131locak","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2020021108405185000_B11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0039-6257(03)00056-0","article-title":"Ligneous conjunctivitis","volume":"48","author":"Schuster","year":"2003","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"2020021108405185000_B12","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1182\/blood.V91.5.1616","article-title":"Ligneous conjunctivitis in plasminogen-deficient mice","volume":"91","author":"Drew","year":"1998","journal-title":"Blood"},{"issue":"23","key":"2020021108405185000_B13","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1056\/NEJM199812033392305","article-title":"Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency","volume":"339","author":"Schott","year":"1998","journal-title":"N Engl J Med"},{"key":"2020021108405185000_B14","first-page":"183","article-title":"Physiological functions of plasminogen activation: effects of gene deficiencies in humans and mice","author":"Bugge","year":"2008"},{"issue":"9","key":"2020021108405185000_B15","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1161\/01.CIR.92.9.2585","article-title":"Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice","volume":"92","author":"Ploplis","year":"1995","journal-title":"Circulation"},{"issue":"4","key":"2020021108405185000_B16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0092-8674(00)81390-2","article-title":"Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency","volume":"87","author":"Bugge","year":"1996","journal-title":"Cell"},{"issue":"7","key":"2020021108405185000_B17","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1101\/gad.9.7.794","article-title":"Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction","volume":"9","author":"Bugge","year":"1995","journal-title":"Genes Dev"},{"issue":"9","key":"2020021108405185000_B18","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1182\/blood-2005-02-0577","article-title":"The effects of intrinsic pathway protease deficiencies on plasminogen-deficient mice","volume":"106","author":"Cheng","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2020021108405185000_B19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nm0396-287","article-title":"Impaired wound healing in mice with a disrupted plasminogen gene","volume":"2","author":"R\u00f8mer","year":"1996","journal-title":"Nat Med"},{"issue":"1","key":"2020021108405185000_B20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.ATV.0000193624.28251.83","article-title":"What does it take to make the perfect clot?","volume":"26","author":"Monroe","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2020021108405185000_B21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"issue":"4","key":"2020021108405185000_B22","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1055\/s-0037-1616530","article-title":"The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration","volume":"86","author":"Mosnier","year":"2001","journal-title":"Thromb Haemost"},{"issue":"1","key":"2020021108405185000_B23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood.V99.1.175","article-title":"Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A","volume":"99","author":"Lisman","year":"2002","journal-title":"Blood"},{"issue":"6","key":"2020021108405185000_B24","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1538-7836.2003.00242.x","article-title":"The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII\/FIX","volume":"1","author":"He","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2020021108405185000_B25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.2005.05820.x","article-title":"High dose factor VIIa improves clot structure and stability in a model of haemophilia B","volume":"131","author":"Wolberg","year":"2005","journal-title":"Br J Haematol"},{"issue":"suppl 3","key":"2020021108405185000_B26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2516.2010.02253.x","article-title":"Plasma and cellular contributions to fibrin network formation, structure and stability","volume":"16","author":"Wolberg","year":"2010","journal-title":"Haemophilia"},{"issue":"5","key":"2020021108405185000_B27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1538-7836.2009.03306.x","article-title":"Discordant fibrin formation in hemophilia","volume":"7","author":"Brummel-Ziedins","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2020021108405185000_B28","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1111\/j.1365-2516.2011.02648.x","article-title":"Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A","volume":"18","author":"Foley","year":"2012","journal-title":"Haemophilia"},{"issue":"5","key":"2020021108405185000_B29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2141.1971.tb07061.x","article-title":"Epsilon-aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: a double blind controlled trial","volume":"20","author":"Walsh","year":"1971","journal-title":"Br J Haematol"},{"issue":"6","key":"2020021108405185000_B30","first-page":"427","article-title":"Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system","volume":"38","author":"Sindet-Pedersen","year":"1991","journal-title":"Dan Med Bull"},{"issue":"7","key":"2020021108405185000_B31","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/jth.14148","article-title":"Abrogating fibrinolysis does not improve bleeding or rFVIIa\/rFVIII treatment in a non-mucosal venous injury model in haemophilic rodents","volume":"16","author":"Stagaard","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2020021108405185000_B32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1351-8216.2003.00839.x","article-title":"Role of epsilon amino caproic acid in the management of haemophilic patients with inhibitors","volume":"10","author":"Ghosh","year":"2004","journal-title":"Haemophilia"},{"issue":"3","key":"2020021108405185000_B33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/hae.12318","article-title":"Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors","volume":"20","author":"Tran","year":"2014","journal-title":"Haemophilia"},{"issue":"3","key":"2020021108405185000_B34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2516.2008.01950.x","article-title":"Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations","volume":"15","author":"Hermans","year":"2009","journal-title":"Haemophilia"},{"issue":"2","key":"2020021108405185000_B35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/hae.12028","article-title":"Consensus recommendations for the use of FEIBA(\u00ae) in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery","volume":"19","author":"Rangarajan","year":"2013","journal-title":"Haemophilia"},{"issue":"4","key":"2020021108405185000_B36","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1111\/hae.12942","article-title":"Multimodal blood loss prevention approach including intra-articular tranexamic acid in primary total knee arthroplasty for patients with severe haemophilia A","volume":"22","author":"Rodriguez-Merchan","year":"2016","journal-title":"Haemophilia"},{"issue":"1","key":"2020021108405185000_B37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A [letter]","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"issue":"3","key":"2020021108405185000_B38","first-page":"3015","article-title":"A new mouse model for wound healing in hemophilia A","volume":"8","author":"Gao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"2020021108405185000_B39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1538-7836.2008.02954.x","article-title":"Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice","volume":"6","author":"\u00d8vlisen","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2020021108405185000_B40","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1172\/JCI20741","article-title":"Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2\/Mac-1 is critical for host inflammatory response in vivo","volume":"113","author":"Flick","year":"2004","journal-title":"J Clin Invest"},{"issue":"8","key":"2020021108405185000_B41","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/art.38639","article-title":"Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice","volume":"66","author":"Cole","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"2020021108405185000_B42","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1172\/JCI30134","article-title":"Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif","volume":"117","author":"Flick","year":"2007","journal-title":"J Clin Invest"},{"issue":"8","key":"2020021108405185000_B43","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1172\/JCI92744","article-title":"Thrombin promotes diet-induced obesity through fibrin-driven inflammation","volume":"127","author":"Kopec","year":"2017","journal-title":"J Clin Invest"},{"issue":"3","key":"2020021108405185000_B44","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1182\/blood-2008-07-169003","article-title":"Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain","volume":"113","author":"Mullins","year":"2009","journal-title":"Blood"},{"issue":"24","key":"2020021108405185000_B45","doi-asserted-by":"crossref","first-page":"15333","DOI":"10.1073\/pnas.242501899","article-title":"Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction","volume":"99","author":"Pawlinski","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2020021108405185000_B46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3727\/096368915X686850","article-title":"Extramedullary hematopoiesis (EMH) in laboratory animals: offering an insight into stem cell research","volume":"24","author":"Chiu","year":"2015","journal-title":"Cell Transplant"},{"issue":"3","key":"2020021108405185000_B47","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/0300985811432344","article-title":"Extramedullary hematopoiesis: a new look at the underlying stem cell niche, theories of development, and occurrence in animals","volume":"49","author":"Johns","year":"2012","journal-title":"Vet Pathol"},{"issue":"3 Pt 2","key":"2020021108405185000_B48","first-page":"H769","article-title":"Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation","volume":"274","author":"Le","year":"1998","journal-title":"Am J Physiol"},{"issue":"2","key":"2020021108405185000_B49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ajh.2830500202","article-title":"Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation","volume":"50","author":"Chang","year":"1995","journal-title":"Am J Hematol"},{"issue":"6","key":"2020021108405185000_B50","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","article-title":"A cell-based model of hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb Haemost"},{"issue":"12","key":"2020021108405185000_B51","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1073\/pnas.93.12.5899","article-title":"Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator","volume":"93","author":"Bugge","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2020021108405185000_B52","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood-2012-09-455436","article-title":"Hepatocyte tissue factor activates the coagulation cascade in mice","volume":"121","author":"Sullivan","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2020021108405185000_B53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1600-0676.2000.020001003.x","article-title":"Morphological mechanisms for regulating blood flow through hepatic sinusoids","volume":"20","author":"McCuskey","year":"2000","journal-title":"Liver"},{"issue":"1","key":"2020021108405185000_B54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-5926-1-1","article-title":"Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review","volume":"1","author":"Braet","year":"2002","journal-title":"Comp Hepatol"},{"issue":"2","key":"2020021108405185000_B55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0049-3848(95)00157-M","article-title":"Blood coagulation equilibrium in rat liver microcirculation as evaluated by endothelial cell thrombomodulin and macrophage tissue factor","volume":"80","author":"Arai","year":"1995","journal-title":"Thromb Res"},{"issue":"6","key":"2020021108405185000_B56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0049-3848(97)00038-8","article-title":"Recombinant human tissue factor pathway inhibitor as a possible anticoagulant targeting hepatic sinusoidal walls","volume":"85","author":"Yamanobe","year":"1997","journal-title":"Thromb Res"},{"issue":"5","key":"2020021108405185000_B57","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/oxfordjournals.jbchem.a123818","article-title":"cDNA cloning and expression of rat tissue factor pathway inhibitor (TFPI)","volume":"111","author":"Enjyoji","year":"1992","journal-title":"J Biochem"},{"key":"2020021108405185000_B58","first-page":"67","article-title":"Mouse models of coagulation factor deficiencies for translational research","author":"McManus","year":"2012"},{"issue":"8","key":"2020021108405185000_B59","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1160\/TH16-12-0920","article-title":"Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation","volume":"117","author":"Stroo","year":"2017","journal-title":"Thromb Haemost"},{"issue":"2","key":"2020021108405185000_B60","doi-asserted-by":"crossref","first-page":"L163","DOI":"10.1152\/ajplung.00320.2016","article-title":"Factor XI deficiency enhances the pulmonary allergic response to house dust mite in mice independent of factor XII","volume":"312","author":"Stroo","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"20","key":"2020021108405185000_B61","doi-asserted-by":"crossref","first-page":"11068","DOI":"10.1073\/pnas.93.20.11068","article-title":"Identification of the endothelial cell binding site for factor IX","volume":"93","author":"Cheung","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2020021108405185000_B62","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1111\/jth.12421","article-title":"Evidence of clinically significant extravascular stores of factor IX [letter]","volume":"11","author":"Feng","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2020021108405185000_B63","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/j.1538-7836.2009.03545.x","article-title":"Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV","volume":"7","author":"Gui","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2020021108405185000_B64","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/hae.12907","article-title":"Development of a tail vein transection bleeding model in fully anaesthetized haemophilia A mice - characterization of two novel FVIII molecules","volume":"22","author":"Johansen","year":"2016","journal-title":"Haemophilia"},{"issue":"suppl 2","key":"2020021108405185000_B65","first-page":"315","article-title":"In vivo effect of recombinant FVIIa (NovoSeven \u00ae) and rFIX in a refined tail vein transection bleeding model in anaesthetized mice with haemophilia A or B [abstract]","volume":"13","author":"Johansen","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"15","key":"2020021108405185000_B66","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2018-01-828434","article-title":"Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding","volume":"132","author":"Wyseure","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2020021108405185000_B67","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0002-9440(10)64914-0","article-title":"Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis","volume":"160","author":"Cook","year":"2002","journal-title":"Am J Pathol"},{"issue":"2","key":"2020021108405185000_B68","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4049\/jimmunol.167.2.1047","article-title":"Tissue-type plasminogen activator deficiency exacerbates arthritis","volume":"167","author":"Yang","year":"2001","journal-title":"J Immunol"},{"issue":"3","key":"2020021108405185000_B69","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0002-9440(10)62299-7","article-title":"The plasminogen activator\/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis","volume":"166","author":"Li","year":"2005","journal-title":"Am J Pathol"},{"issue":"1","key":"2020021108405185000_B70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1172\/JCI2312","article-title":"Exacerbation of antigen-induced arthritis in urokinase-deficient mice","volume":"102","author":"Busso","year":"1998","journal-title":"J Clin Invest"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/22\/3126\/1630103\/advances024851.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/22\/3126\/1630103\/advances024851.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T09:18:36Z","timestamp":1581412716000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/22\/3126\/16131\/Absence-of-functional-compensation-between"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":70,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2018,11,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018024851","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]}}}